Skip to content

Echo Therapeutics, Inc.

CIK 0001031927

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q3 Oct 2016
Net Income (TTM)
−$6.54M
−48.4% YoY Q3 Oct 2016
EPS Diluted (TTM)
—
Q3 Oct 2016
Gross Margin
—
Q3 Oct 2016
Operating Margin
—
Q3 Oct 2016
Net Margin
—
Q3 Oct 2016
Free Cash Flow (TTM)
—
Q3 Oct 2016
Cash
$172.73K
Q3 Oct 2016
Total Debt
—
Q3 Oct 2016
Shares Outstanding
12M sh
Q3 Oct 2016

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings